Tradestie Institutional Equity Comparison Engine
EW vs RBOT.WS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EW Overall Edge
EW Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Edwards Lifesciences Corp (EW) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, EW trades at 30.1x Forward P/E with 28.8% operating margin (+10.5% YoY revenue) versus RBOT.WS at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, EW sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against RBOT.WS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
EW
EW 30.1x vs RBOT.WS N/M Fwd P/E
Growth & Margin Winner
EW
Op Margin 28.8% vs N/A ยท YoY +10.5% vs N/A
Momentum & Technical Winner
EW
1Y +18.4% vs -67.2% ยท 52W Pos 82% vs 0%
Options & Structure Winner
EW
UNCLASSIFIED (100th %ile IV) vs UNCLASSIFIED (N/A IV)
EW
NYSE
Edwards Lifesciences Corp
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$101.85
-1.95% 1D
Market Cap
$59.7B
1M Return
+13.05%
1Y Return
+18.4%
Forward P/E
30.1x
Unified AI Score
40.0 / 100
SELL
Tech 24.0
Fund 43.0
Flow 55.0
Mom 60.0
RBOT.WS
NYSE
Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of Class A Common Stock at an exercise price of $345.00
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.01
-24.77% 1D
Market Cap
N/A
1M Return
-67.2%
1Y Return
-67.2%
Forward P/E
N/M
Unified AI Score
50.1 / 100
HOLD
Tech 40.0
Fund 46.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
EW +18.4%
RBOT.WS -67.2%
Spread: +66.45 pp (EW Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
EW TTM Op. Margin: 28.8%
RBOT.WS TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EW vs RBOT.WS. Trailing 12-month operating profitability (EW 28.8% vs RBOT.WS N/A) and valuation multiples (EW 30.1x vs RBOT.WS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EW | RBOT.WS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $59.7B | N/A | Larger Scale | EW |
| Trailing P/E Ratio Valuation | 60.4x | N/M | Lower Multiple | EW |
| Forward P/E Ratio Valuation | 30.1x | N/M | Lower Multiple | EW |
| Revenue Growth (YoY) Growth | +10.5% | N/A | Higher Growth | EW |
| Operating Margin (TTM) Profitability | 28.8% | N/A | Higher Margin | EW |
| Net Profit Margin Profitability | 15.3% | N/A | Higher Margin | EW |
| Return on Equity (ROE) Capital Efficiency | 9.3% | N/A | Higher ROE | EW |
| 52-Week Range Position Momentum | 82% ($75โ$108) | 0% ($0โ$0) | Stronger Trend | EW |
| Beta / 30D Volatility Risk Regime | 0.43ฮฒ ยท 27% Vol | N/A | Lower Realized Risk | EW |
| Unified Institutional Score Composite Signal | 40.0 / 100 (SELL) | 50.1 / 100 (HOLD) | Higher Composite | RBOT.WS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full EW vs RBOT.WS Buy Guide
EW
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
RBOT.WS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither EW nor RBOT.WS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.